Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving the Diagnosis and Treatment of Cardiovascular Diseases in Kazakhstan by Introducing Correction of Metabolism With Glucagon-like Peptide 1 (GLP-1) Drugs

NCT07303556 is registered in ClinicalTrials.gov with Nazarbayev University as lead sponsor.

NCT NCT07303556
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07303556 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving the Diagnosis and Treatment of Cardiovascular Diseases in Kazakhstan by Introducing Correction of Metabolism With Glucagon-like Peptide 1 (GLP-1) Drugs
Lead sponsor
Nazarbayev University
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 18, 2024
Completion date
November 1, 2026
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arterial hypertension, diabete type 2, heart failure